First, a disambiguation that matters more here than on any other page on this site. A bone marrow transplant, also called a hematopoietic stem cell transplant or HSCT, is an established cancer and blood-disorder treatment delivered in a hospital, covered by insurance and Medicare, and billed in the hundreds of thousands of dollars. It is not the same thing as the “stem cell therapy” sold by clinics for knee pain and anti-aging, which is largely not FDA-approved and is priced in the thousands. If you are researching joint injections rather than leukemia treatment, our stem cell therapy cost guide is the page you want.
Second, a framing point. A transplant is not a cash purchase. BMT InfoNet, a nonprofit patient education organization, states that if you do not have health insurance your transplant center may advise you on how to apply for coverage or will require a significant deposit before beginning treatment. So the useful questions are what the episode bills, what actually gets paid, and where the assistance money is. Every figure below was verified on September 5, 2026.
What Does a Bone Marrow Transplant Cost Without Insurance?
Two independent sources describe the price, and they measure different things. Milliman’s periodic transplant report estimates billed charges across a nine-month episode. CMS claims data shows what hospitals submitted for the admission and what was paid on it. Both split autologous from allogeneic, which is the split that matters.
| Service / Type | Low | Average | High |
|---|---|---|---|
| Autologous transplant, total billed charges (Milliman 2025) | n/a | $577,000 | n/a |
| Allogeneic transplant, total billed charges (Milliman 2025) | n/a | $1,261,800 | n/a |
| 30 days pre-transplant (autologous vs. allogeneic, billed) | $77,900 | n/a | $94,300 |
| Procurement, including donor search and collection | $36,100 | n/a | $97,400 |
| Hospital transplant admission | $275,500 | n/a | $669,300 |
| Physician services during the admission | $11,500 | n/a | $18,900 |
| 180 days of post-transplant care after discharge | $129,800 | n/a | $314,200 |
| Outpatient drugs, first 180 days | $46,200 | n/a | $67,700 |
| Hospital submitted charge, autologous, without vs. with complications (MS-DRG 017/016) | $170,664 | n/a | $273,743 |
| Average total payment on those autologous stays | $53,797 | n/a | $72,541 |
| Hospital submitted charge, allogeneic (MS-DRG 014) | n/a | $579,837 | n/a |
| Average total payment on those allogeneic stays | n/a | $150,978 | n/a |
| CAR T-cell therapy admission, submitted vs. paid (MS-DRG 018) | $464,910 paid | n/a | $2,203,276 billed |
| HLA typing, low resolution (CPT 81370, allowed vs. submitted) | $372 | n/a | $895 |
| Donor marrow harvest (CPT 38230, allowed vs. submitted) | $203 | n/a | $2,289 |
| Stem cell infusion, allogeneic (CPT 38240, allowed vs. submitted) | $237 | n/a | $3,974 |
Sources: Milliman’s February 2025 U.S. organ and tissue transplants report; CMS Medicare Inpatient Hospitals by Geography and Service (MS-DRG 014, 016, 017, 018, 2024 claims); CMS Medicare Physician & Other Practitioners by Geography and Service (2024 claims).
What the payment side looks like
Across 1,178 allogeneic transplant discharges in 2024 Medicare data, hospitals submitted an average charge of $579,837 and were paid an average of $150,978 in total, of which Medicare itself paid $123,292. Across 1,567 autologous discharges with a complication or comorbidity, average submitted charge was $273,743 and average total payment $72,541.
That is roughly 26% of billed charges in both cases, which is a wider payment share than most transplants and reflects how much of the cost is unavoidable inpatient care rather than list-price markup.
The professional fees are almost a rounding error next to the facility bill, but they show the same billed-to-allowed spread you can negotiate against. In 2024, physicians submitted an average of $3,974.21 for CPT 38240 (allogeneic stem cell infusion) and Medicare allowed $236.60, a 17-fold gap. For CPT 38241 (autologous infusion) it was $4,456.88 submitted against $171.50 allowed.
What Drives the Price
Autologous vs. allogeneic, which is most of it
An autologous transplant uses your own stem cells, collected before high-dose chemotherapy and given back afterward. An allogeneic transplant uses a donor’s cells. Milliman’s estimates put the allogeneic total at 2.2 times the autologous total ($1,261,800 against $577,000), and every component line is higher. This is a clinical decision driven by your diagnosis, not a menu choice, but it explains why quoted “bone marrow transplant” prices vary so wildly.
The donor search
For an allogeneic transplant, someone has to be found and matched. Milliman assigns $97,400 to procurement for allogeneic against $36,100 for autologous, covering the search, HLA typing, collection, and transport. The individual lab lines are small: 2024 Medicare data shows low-resolution HLA class I and II typing (CPT 81370) submitting at $895.46 against $372.29 allowed, and high-resolution class I typing (CPT 81379) at $1,194.54 against $328.67. It is the coordination, registry access, and donor workup that make procurement a six-figure line, not the typing itself.
The admission, and how long it runs
The hospital stay is $669,300 of the allogeneic estimate and $275,500 of the autologous one, or more than half of each total. Length of stay is the variable, and it is driven by engraftment, infection, and complications rather than anything you choose. See our guides to hospital stay cost per day and ICU cost per day for how those days price individually.
What happens after discharge
Milliman puts $314,200 of billed charges on the 180 days after an allogeneic transplant, plus $67,700 in outpatient drugs, largely because of graft-versus-host disease and infection prophylaxis. For autologous it is $129,800 and $46,200. This is the phase families most often fail to budget for, because it arrives after everyone has stopped thinking about the transplant as an event.
CAR-T is a different product entirely
CAR T-cell therapy is often discussed in the same breath as transplant, and financially it should not be. It re-engineers your own T cells into a manufactured biologic. In 2024 Medicare claims, MS-DRG 018 carried an average submitted charge of $2,203,276 across 1,675 discharges, with average total payment of $464,910. If a center is discussing CAR-T, treat every cost figure on this page as a floor, not a guide. Related drug costs are covered in our chemotherapy cost guide, Keytruda cost guide, and Revlimid cost guide.
Cash Price vs. Insurance
There is no self-pay rate to shop. Nobody funds a $577,000 to $1.26 million billed episode out of pocket, and transplant centers do not sell one at a prepaid price. BMT InfoNet notes that centers commonly require a significant deposit from uninsured patients, and that health care sharing ministries are generally not treated as insurance by transplant programs, which usually means a deposit as well.
The realistic path is coverage plus assistance. Medicare covers bone marrow transplants under certain conditions, per the Medicare & You 2026 handbook. Commercial plans typically route these to contracted centers of excellence, and going outside that network is the most common way an insured family ends up with a catastrophic balance. BMT InfoNet also points out that a denial is worth reading closely, because insurers sometimes deny the center rather than the treatment, and sometimes the problem is a coding error rather than a coverage judgment.
If you are holding bills from before coverage started, the billed-to-paid gap is your negotiating room. Request an itemized hospital bill first, then work the number using our medical bill negotiation guide and the negotiation script tool.
How to Pay Less
- Work the transplant financial coordinator first. Every program has one, and BMT InfoNet notes that the coordinator, not the patient, requests pre-authorization from the insurer. They also know which grants are open this month, which matters more than it sounds.
- Apply for NMDP grants. NMDP (formerly Be The Match) runs pre-transplant, post-transplant, GVHD, clinical trial travel, and financial crisis grants, plus a fertility preservation grant of up to $10,000 for sickle cell patients. Grants range from $250 to $10,000. Eligibility is based on last month’s household income rather than last year’s, which is the right test when someone has stopped working, and generally must be below 350% of the federal poverty level ($55,860 for a household of one and $115,500 for a household of four in 2026).
- Apply to Blood Cancer United’s co-pay program, and check fund status the same day. The organization formerly known as the Leukemia & Lymphoma Society runs disease-specific co-pay funds with published award levels, currently including $10,000 for graft-versus-host disease, $8,500 for acute lymphoblastic leukemia and Hodgkin lymphoma, $8,000 for chronic myeloid leukemia, $4,500 for chronic lymphocytic leukemia, $4,000 for acute myeloid leukemia, and $3,500 for clinical trial costs. Individual funds open and close with funding, and effective September 1, 2026 several funds cover only Medicare, Medicaid, and TRICARE patients.
- File for hospital charity care in parallel with everything else. Nonprofit hospitals must publish a written financial assistance policy and cannot bill an approved applicant more than Amounts Generally Billed. Start with our hospital charity care guide and the charity care checker.
- Budget the 180 days after discharge, not just the admission. Milliman’s post-discharge and outpatient drug lines total $381,900 for allogeneic and $176,000 for autologous. Ask the pharmacy team about manufacturer assistance and foundation copay funds before discharge, not after the first bill.
- Sanity-check individual line items. The billed-to-allowed spreads on the procedure codes are large enough to be worth reading, and our fair price checker will tell you where a given charge sits. Our blood transfusion cost guide and CBC test cost guide cover two of the most frequently repeated lines on a transplant bill.
Bottom Line
A bone marrow transplant bills roughly $274,000 to $1.26 million, and which end you land on is mostly decided by your diagnosis rather than your shopping. Autologous transplants estimate at $577,000 in billed charges and allogeneic at $1,261,800, while 2024 Medicare claims put average total payment at $72,541 and $150,978.
None of those numbers is the one that decides a family’s outcome. That one is whether coverage is in place at an in-network or Medicare-approved center before treatment starts, and whether the post-discharge costs have a funded plan behind them. Start with the transplant financial coordinator, apply for NMDP and Blood Cancer United assistance in parallel, and treat fundraising as a normal step rather than a last resort. For how the solid-organ side compares, see our guides to kidney transplant cost and heart transplant cost.